Quantcast

Latest Antibody Stories

2014-08-20 08:27:31

MUMBAI, August 20, 2014 /PRNewswire/ -- Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 1302, a HER2xCD3 bispecific antibody. GBR 1302 was discovered and developed by the Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland. GBR 1302 is based on Glenmark's innovative BEAT antibody...

2014-08-18 23:07:59

Request A Test now offers Lyme Disease blood testing which includes an automatic confirmatory test at no additional cost. All Lyme testing is discounted 10% with promo code LYMED10 through August 31, 2014. Brecksville, OH (PRWEB) August 18, 2014 Request A Test, a leading national provider of direct to consumer lab testing, has updated their selection of Lyme Disease blood tests to provide more thorough and accurate screenings. Customers can now order three different types of antibody...

2014-08-04 23:07:27

Save 10% on blood testing for Lyme Disease with promo code LYMED10. This offer expires August 31, 2014. Brecksville, OH (PRWEB) August 04, 2014 This August, Request A Test, a leading national provider of direct to consumer lab testing, is offering 10% off of all testing for Lyme Disease. To take advantage of this discount, customers just need to use promo code LYMED10 when placing an order. Summer is upon us and with everyone spending more time outdoors, the risk for illnesses like...

2014-07-30 12:30:36

Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in highly sensitized patients. C1-INH is a human protein and an important inhibitor of the complement system. http://photos.prnewswire.com/prnvar/20100914/PH63692LOGO The...

2014-07-29 08:32:17

Three new tools for bacterial detection and isolation MILFORD, Mass., July 29, 2014 /PRNewswire/ -- KPL, a SeraCare Company, today announced the addition of three new products to its growing line of BacTrace antibodies: BacTrace(®) Antibody Coated Latex Beads, BacTrace(®) STEC Antibodies, and BacTrace(®) Salmonella CSA-Plus Antibodies. These tools are designed for use by researchers and developers of foodborne pathogen assays. As polyclonals, the BacTrace antibodies can be used as...

2014-07-10 12:30:51

ST. PETERSBURG, Russia, July 10, 2014 /PRNewswire/ -- On July 9 Prime Minister of the Russian Federation Dmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical company BIOCAD [http://biocad.ru/en ]. The Company is developing a unique project called MabNext [http://biocad.ru/en/science ]. Within the scope of MabNext project BIOCAD develops a number of innovative drugs based on monoclonal antibodies for treatment of cancer and autoimmune...

2014-07-08 04:21:35

OXFORD, England and SAN JOSE, California, July 8, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, announced today the appointment of Eugen Leo, MD, PhD, MBA, as Head of Clinical Development. Dr. Leo brings substantial clinical development experience of targeted and first-in-class molecules, as well as extensive translational research...

First Antibodies To Treat Cancer In Dogs Developed
2014-07-07 03:10:21

University of Veterinary Medicine Vienna Nearly every second dog develops cancer from the age of ten years onward. A few therapies derived from human medicine are available for dogs. A very successful form of therapy by which antibodies inhibit tumor growth has not been available for animals so far. Scientists at the inter-university Messerli Research Institute of the Vetmeduni Vienna, the Medical University of Vienna, and the University of Vienna have developed, for the first time,...

2014-07-03 08:23:49

MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting OX40, a co-stimulatory receptor on T cells - The antibody has successfully completed the Phase I enabling preclinical development program and a Phase I clinical trial application has been filed with The Netherlands authorities -...

2014-07-01 12:28:27

COLLEGE PARK, Md., July 1, 2014 /PRNewswire-USNewswire/ --The University of Maryland (UMD) Fischell Department of Bioengineering and the Maryland Center for Excellence in Regulatory Science (M-CERSI) have partnered with the Global Biological Standards Institute (GBSI) to launch the Collaboration to Advance Antibody Standards. This collaboration between the Fischell Department of Bioengineering and GBSI will allow for assessment of the current antibody standards landscape and...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.